The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multicenter prospective phase II study of sunitinib in non-clear cell type renal cell carcinoma.
Jae-Lyun Lee
No relevant relationships to disclose
Jin-Hee Ahn
No relevant relationships to disclose
Hoyeong Lim
No relevant relationships to disclose
Se-Hoon Lee
No relevant relationships to disclose
Tae Min Kim
No relevant relationships to disclose
Dae Ho Lee
No relevant relationships to disclose
Yong Mee Cho
No relevant relationships to disclose
Jun Hyuk Hong
No relevant relationships to disclose
Choung-Soo Kim
No relevant relationships to disclose
Hanjong Ahn
No relevant relationships to disclose